
Apollo Hospitals Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 1
Fundraise
N/A
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
Category 2- Pharmacy front-end business expected to grow over 20% in FY '26 and beyond.
- Digital business (Apollo 24/7) targeting 25%-30% GMV growth annually; aiming for INR 1,000 crore GMV to breakeven.
- Apollo HealthCo revenues grew 17% YoY in Q4, supported by omnichannel pharmacy and double-digit GMV growth; aiming to hit around INR 24,000 to 25,000 crore by FY '27.
- Diagnostics business targeting 2%-3% margin improvement this year; aiming for 20% EBITDA margin in next 2-3 years with volume growth through lab expansions.
- Apollo Pharmacy aims to increase market share from current 8% to 20% in 5-6 years by adding 600 stores annually and expanding to new geographies.
- Specialty clinics and primary care clinics expected to grow in high teens.
- Digital insurance business started contributing; expected to grow significantly next year.
- New hospitals and bed additions planned, with operational expansion in Q3/Q4 FY '26 enhancing volumes and revenues.
See what Apollo Hospitals management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The transcript provided from the earnings call does not mention any specific current or future plans for fundraising through debt or equity.
- The company highlights having significant cash and cash equivalents on hand and generating healthy free cash flows in excess of INR 1,000 crore per year after routine items.
- It mentions confidence in funding portfolio expansion (INR 6,000 crore over 3-4 years) primarily through existing funds and internal accruals, without indicating the need for additional fundraising.
- No direct references to new debt issuance or equity raising initiatives were found on the discussed pages.
See what Apollo Hospitals management said on order book — free account, 30 seconds.
Capex plans
Yes- Apollo Hospitals is committed to spending over INR 8,000 crore for adding 4,300 beds over the next 3 to 4 years.
- INR 1,000 crore has already been spent on land acquisition and project development; the balance INR 6,000 crore will be spent over the next 3 to 4 years.
- Key projects include operationalizing facilities in Gurgaon, Pune, Kolkata, Hyderabad, and significant expansion in Bangalore's Sarjapur area with 700 additional beds via acquisition and greenfield development.
- Expansion also planned in Jubilee Hills, Secunderabad, and Gachibowli Hyderabad, boosting overall bed strength to 1,500 in Hyderabad and Bangalore.
- Apollo HealthCo is advancing the Keimed merger with 15 months timeline for completion.
- New insurance partnerships for Apollo 24/7 are expected to drive revenue, with no losses anticipated this fiscal year but significant margin increases expected next year.
- No intention to tie up with quick commerce platforms; focus remains on building in-house digital capabilities.
Track Apollo Hospitals — get its next earnings analysis in your feed
How does Apollo Hospitals rank vs peers in Healthcare Services?
Pro featureHow does Apollo Hospitals rank in Healthcare Services?
Compare Apollo Hospitals against every Healthcare Services company (Q4 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Apollo Hospitals's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.